Brian Gorman
Algemeen Adviseur bij CALLIDITAS THERAPEUTICS AB
Profiel
Brian Gorman is currently the Group General Counsel at Calliditas Therapeutics AB since 2024.
Prior to this, he worked as the EVP-Corporate Development & General Counsel at Opiant Pharmaceuticals, Inc. and as the Vice President & Assistant General Counsel at Endo Pharmaceuticals, Inc. He completed his undergraduate degree at Gettysburg College and his graduate degree at Villanova University School of Law.
Actieve functies van Brian Gorman
Bedrijven | Functie | Begin |
---|---|---|
CALLIDITAS THERAPEUTICS AB | Algemeen Adviseur | 01-01-2024 |
Eerdere bekende functies van Brian Gorman
Bedrijven | Functie | Einde |
---|---|---|
OPIANT PHARMACEUTICALS, INC. | Algemeen Adviseur | 02-03-2023 |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Algemeen Adviseur | - |
Opleiding van Brian Gorman
Villanova University School of Law | Graduate Degree |
Gettysburg College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CALLIDITAS THERAPEUTICS AB | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA. | Health Technology |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Health Technology |